Galactorrhea and Hyperprolactinemia

  title={Galactorrhea and Hyperprolactinemia},
  author={R. Sakiyama and M. Quan},
  journal={Obstetrical \& Gynecological Survey},
Galactorrhea refers to the secretion of a milky fluid from the breast, occurring either spontaneously or with manual expression, in the absence of pregnancy or the postpartum state. The development of a sensitive and specific radioimmunoassay for human prolactin during the last decade along with improved neuroradiologic techniques have greatly expanded understanding of nonpuerperal lactation. Discussion reviews the pevalence of galactorrhea, the etiology of hyperprolactinemia and/or… Expand
Incidence of Galactorrhea in Young Women Using Depot-Medroxyprogesterone Acetate
It appears that galactorrhea is a benign side effect and as previous reports have suggested, it did not seem to be related to changes in Prolactin levels in the authors' patients. Expand
Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
A review of the diagnosis and treatment of hyperprolactinemia and prolactinomas, emphasizing controversial issues regarding these topics is provided, based on data published in the literature and the authors' experience. Expand
Hyperprolactinemia and prolactinoma.
  • J. Romijn
  • Medicine
  • Handbook of clinical neurology
  • 2014
The cardiac adverse effects of dopamine agonists reported in Parkinson's disease are not of clinical concern in the treatment of prolactinomas, which are treated with much lower doses, and there is uncertainty with respect to the dose and duration of cabergoline treatment. Expand
Drugs and prolactin
In the individual patient, it is important differentiate hyperprolactinemia due to a medication from a structural lesion in the hypothalamic–pituitary area, which can be done by stopping the medication temporarily to determine if the prolactin (PRL) levels return to normal. Expand
Chapter 6 – Amenorrhoea
This chapter discusses primary amenorrhea at 16 years of age, and detailed investigation is indicated because there is an increased risk of malignancy if the gonads are not removed in a girl with a Y chromosome. Expand
Medical Management of Prolactin-Secreting Pituitary Adenomas
Imaging with MRI or CT will delineate the size and extent of the tumor, and bromocriptine use has an extensive safety experience and is preferred, however, for other indications, cabergoline appears to be more efficacious and better tolerated. Expand
Acute lymphoblastic leukaemia presenting with galactorrhoea
Both the ectopic prolactin mRNA and galactorrhoea eventually resolved upon disease remission after treatment, and the presence of prolactIn mRNA in the patient's marrow at diagnosis was supported. Expand
Burns, hypertrophic scar and galactorrhea
It seems that refractory hypertrophic scar is related to the high level of prolactin in burns patients, which was found on an 18-year old woman admitted to Motahari Burn Center with 30% burns. Expand
Galactorrhea caused by esophagitis.
It is proposed that the mechanism of production of galactorrhea is similar to that seen with chest wall lesions, and this cause should be kept in mind when evaluating unusual causes of gal actorrhea. Expand
Hormonal side effects in women: typical versus atypical antipsychotic treatment.
This work uses case vignettes to discuss assessment and management of clinical situations that arise as a result of antipsychotic-induced endocrine changes, and offers prevention and resolution of these adverse reactions. Expand